Correlation Between Pulmatrix and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Akari Therapeutics PLC, you can compare the effects of market volatilities on Pulmatrix and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Akari Therapeutics.
Diversification Opportunities for Pulmatrix and Akari Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pulmatrix and Akari is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Pulmatrix i.e., Pulmatrix and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Pulmatrix and Akari Therapeutics
Given the investment horizon of 90 days Pulmatrix is expected to generate 1.16 times more return on investment than Akari Therapeutics. However, Pulmatrix is 1.16 times more volatile than Akari Therapeutics PLC. It trades about 0.14 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about 0.0 per unit of risk. If you would invest 183.00 in Pulmatrix on August 25, 2024 and sell it today you would earn a total of 429.00 from holding Pulmatrix or generate 234.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pulmatrix vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Pulmatrix |
| Akari Therapeutics PLC |
Pulmatrix and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pulmatrix and Akari Therapeutics
The main advantage of trading using opposite Pulmatrix and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
| Akari Therapeutics vs. Lyra Therapeutics | Akari Therapeutics vs. Hookipa Pharma | Akari Therapeutics vs. SAB Biotherapeutics | Akari Therapeutics vs. Cadrenal Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |